BioStem Technologies Inc
PublicBioStem Technologies Inc is now publicly traded
The data on this page reflects BioStem Technologies Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Sep 21, 2026
Total Funding Raised
$2.73M
Company Overview
BioStem Technologies Inc operates in Healthcare and is based in the United States. It has raised $2.73M.
BioStem Technologies Inc is a regenerative medicine company that develops, manufactures, and commercializes placental-derived allografts for advanced wound care and surgical applications.
Sector
Healthcare
AI Layer
Non-AI
BioStem Technologies Inc Comparables
Compare BioStem Technologies Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Skye Biologics Holdings | 86% | |
| Merakris Therapeutics | 75% | |
| CTM Biomedical | 75% |
For institutional investors. Book with your work email.
BioStem Technologies Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Sep 21, 2026 | ||||
| Private Placement | May 21, 2026 | ||||
| Private Placement | Mar 9, 2023 | ||||
| Private Placement | Aug 9, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioStem Technologies Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.